King's College London

Cerebrospinal luid viral escape and acute encephalitis in a patient on boosted protease inhibitor monotherapy

Tiraboschi, J., Hamzah, L., Siddiqui, A., Kulasegaram, R., Post, F. & Fox, J., 1 Oct 2016, In: ANTIVIRAL THERAPY. 21, 5, p. 461-464 4 p.

Research output: Contribution to journal › Article › peer-review

Effects on vitamin D, bone and the kidney of switching from fixed-dose tenofovir disoproxil fumarate/emtricitabine/efavirenz to darunavir/ritonavir monotherapy: a randomized, controlled trial (MIDAS)

Hamzah, L., Tiraboschi, J. M., Iveson, H., Toby, M., Mant, C., Cason, J., Burling, K., Wandolo, E., Jendrulek, I., Taylor, C., Ibrahim, F., Kulasegaram, R., Teague, A., Post, F. A. & Fox, J., 13 Oct 2015, In: ANTIVIRAL THERAPY. 10 p.

Research output: Contribution to journal › Article › peer-review

The prevalence of darunavir-associated mutations in HIV-1-infected children in the UK

Donegan, K. L., Walker, A. S., Dunn, D., Judd, A., Pillay, D., Mason, E., Lyall, H., Tudor-Williams, G., Gibb, D. M., Collaborative HIV Paediat Study & UK HIV Drug Resistance Database, 2012, In: ANTIVIRAL THERAPY. 17, 4, p. 599-603 5 p.

Research output: Contribution to journal › Article › peer-review

Outcomes in the first year after initiation of first-line HAART among heterosexual men and women in the UK CHIC Study

Barber, T. J., Geretti, A. M., Anderson, J., Schwenk, A., Phillips, A. N., Bansi, L., Gilson, R., Hill, T., Walsh, J., Fisher, M., Johnson, M., Post, F., Easterbrook, P., Gazzard, B., Palfreeman, A., Orkin, C., Leen, C., Gompels, M., Dunn, D., Delpech, V., & 3 othersPillay, D., Sabin, C. A. & UK CHIC Study Steering Committee, 2011, In: ANTIVIRAL THERAPY. 16, 6, p. 805-814 10 p., N/A.

Research output: Contribution to journal › Article › peer-review

Effects of ethnicity, renal function and tenofovir/protease inhibitor co-administration on tubular biomarkers

Campbell, L., Dew, T., Salota, R., Cheserem, E., Hamzah, L., Moniz, C., Poulton, M., Sherwood, R., Hendry, B. & Post, F., 2010, In: ANTIVIRAL THERAPY. 15, 8, p. A73 - A73

Research output: Contribution to journal › Meeting abstract

Use of CKD-EPI and MDRD to estimate baseline renal function as predictor of mortality in HIV-infected patients

Ibrahim, F., Hamzah, L., Jones, R., Nitsch, D., Sabin, C. & Post, F., 2010, In: ANTIVIRAL THERAPY. 15, 8, p. A21 - A22 2 p.

Research output: Contribution to journal › Meeting abstract

Factors influencing efavirenz and nevirapine plasma concentration: effect of ethnicity, weight and co-medication

Stohr, W., Back, D., Dunn, D., Sabin, C., Winston, A., Gilson, R., Pillay, D., Hill, T., Ainsworth, J., Pozniak, A., Leen, C., Bansi, L., Fisher, M., Orkin, C., Anderson, J., Johnson, M., Easterbrook, P., Gibbons, S. & Khoo, S., 2008, In: ANTIVIRAL THERAPY. 13, 5, p. 675 - 685 11 p.

Research output: Contribution to journal › Article › peer-review

Correlation of sensitivity of primary R5 HIV-1 to RANTES and small-molecule R5 inhibitors.

Koning, FA., Koevoets, C., van der Vorst, TJK. & Schuitemaker, H., 2005, In: ANTIVIRAL THERAPY. 10, p. 231 - 237 7 p.

Research output: Contribution to journal › Article › peer-review

Design and characterization of human respiratory syncytial virus entry inhibitors

Ni, L., Zhao, L. Q., Qian, Y., Zhu, J. Q., Jin, Z. B., Chen, Y. W., Tien, P. & Gao, G. F., 2005, In: ANTIVIRAL THERAPY. 10, 7, p. 833 - 840 8 p.

Research output: Contribution to journal › Article › peer-review

Low density lipoprotein apolipoprotein B metabolism in treatment-naive HIV patients and patients on antiretroviral therapy

Umpleby, A. M., Das, S., Stolinski, M., Shojaee-Moradie, F., Jackson, N. C., Jefferson, W., Crabtree, N., Nightingale, P. & Shahmanesh, M., 2005, In: ANTIVIRAL THERAPY. 10, 5, p. 663 - 670 8 p.

Research output: Contribution to journal › Article › peer-review

Pravastatin does not enhance in vitro changes in mitochondrial DNA and RNA caused by nucleoside reverse transcriptase inhibitors

van Schilfgaarde, M., Smolders, K. G. M., Buitelaar, M. & de Baar, M. P., 2005, In: ANTIVIRAL THERAPY. 10, 8, p. L45-L45 1 p.

Research output: Contribution to journal › Meeting abstract › peer-review

Sensitivity of primary R5 HIV-1 to inhibition by RANTES correlates with sensitivity to small-molecule R5 inhibitors

Koning, F. A., Koevoets, C., van der Vorst, T. J. K. & Schuitemaker, H., 2005, In: ANTIVIRAL THERAPY. 10, 2, p. 231 - 237 7 p.

Research output: Contribution to journal › Article › peer-review

Drug resistance genotypes predict response to amprenavir-containing regimens in highly drug-experienced HIV-1 infected patients

Sabin, C. A., Wilkins, E., Murphy, M., Fisher, M., de Ruiter, A., Easterbrook, P. J., Leen, C., Vlahakis, E., Cane, P. A., Li, X. & Pillay, D., Aug 2003, In: ANTIVIRAL THERAPY. 8, 4, p. 301 - 308 8 p.

Research output: Contribution to journal › Article › peer-review

Frequency of serious psychiatric adverse events with efavirenz

Allin, M., Reeves, I., Tennant-Flowers, M. & Everall, I., 2003, In: ANTIVIRAL THERAPY. 8, 4, p. 129 1 p.

Research output: Contribution to journal › Meeting abstract

Mutations in HIV-1 reverse transcriptase during therapy with abacavir, lamivudine and zidovudine in HIV-1-infected adults with no prior antiretroviral therapy

CNA3003 Int Study Team, Rakik, A., Griffin, P., Cutrell, A., Fischl, A. A., Clumeck, N., Greenberg, S. B., Rubio, R., Peters, B. S., Pulido, F., Gould, J., Pearce, G., Spreen, W., Tisdale, A. & Lafon, S., Mar 2002, In: ANTIVIRAL THERAPY. 7, 1, p. 43 - 51 9 p.

Research output: Contribution to journal › Article › peer-review

HCV polymerase inhibition by ribose modified ribavirin analogues

Dutartre, H., Sophys, M., Gallois-Montbrun, S., Chen, Y., Morera, S., Guerreiro, C., Schneider, B., Mulard, L., Janin, J., Veron, M., ville-Bonne, D. & Canard, B., 2002, In: ANTIVIRAL THERAPY. 7, 4, p. L102 - L102

Research output: Contribution to journal › Meeting abstract